Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
出版信息
Lancet. 1973 Mar 31;1(7805):727.
PMID:4120530
Abstract
摘要
相似文献
1
Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
Lancet. 1973 Mar 31;1(7805):727.
2
Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.髓细胞性白血病合并弓形虫病联合治疗后的致命结局。
Lancet. 1973 Mar 17;1(7803):600. doi: 10.1016/s0140-6736(73)90740-x.
3
[Stages in the prophylaxis of toxoplasmosis].
Zentralbl Gynakol. 1970 Dec 19;92(51):1689-92.
4
Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy.
Arch Intern Med. 1975 Jul;135(7):950-4. doi: 10.1001/archinte.135.7.950.
5
The effect of remission induction in acute myeloblastic leukemia on efficiency of colony formation in culture.
Ser Haematol. 1972;5(2):179-88.
6
Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.阿糖胞苷（NSC - 63878）和柔红霉素（NSC - 82151）在急性髓性白血病中的序贯治疗。
Cancer Treat Rep. 1976 May;60(5):629-31.
7
Endomyocardial fibrosis associated with daunorubicin therapy.与柔红霉素治疗相关的心内膜心肌纤维化。
Br Heart J. 1976 Aug;38(8):860-3. doi: 10.1136/hrt.38.8.860.
8
Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol. 1979 Aug;23(2):119-23.
9
The disappearance of ring sideroblasts in myeloblastic leukaemia in remission.髓细胞性白血病缓解期环形铁粒幼细胞的消失。
Scand J Haematol. 1971;8(3):177-9. doi: 10.1111/j.1600-0609.1971.tb01969.x.
10
[The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].[阿糖胞苷和柔红霉素对儿童急性髓细胞白血病细胞动力学的影响]
Rinsho Ketsueki. 1973 Jul;14(7):762-8.
Zotero 插件